Report Library
View More
Wet Age-Related Macular Degeneratio...
May 12, 2025
Datamonitor Healthcare Oncology Dis...
May 9, 2025
2025 Biomedtracker Datamonitor Hea...
May 8, 2025
Wet AMD KOL- France
May 8, 2025
Datamonitor Healthcare Oncology: NH...
May 8, 2025
Wet AMD KOL- US, South
May 7, 2025
Datamonitor Healthcare Infectious D...
May 6, 2025
Datamonitor Healthcare CV&Met: Sick...
May 6, 2025
Dealmaking Quarterly Statistics, Q1...
May 5, 2025
Datamonitor Healthcare I&I: Heredit...
May 1, 2025
Ovarian Cancer - KOL Interview - US...
May 21, 2025
Datamonitor Healthcare Oncology Dis...
May 21, 2025
Datamonitor Healthcare CNS Disease ...
May 21, 2025
Datamonitor Healthcare I&I: Opioid-...
May 21, 2025
Gene, Cell, & RNA Therapy Landscape...
May 16, 2025
Epilepsy KOL Interview - France
May 16, 2025
Datamonitor Healthcare Oncology: Pa...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 14, 2025
Datamonitor Healthcare CNS: Insomni...
May 13, 2025
Wet Age-Related Macular Degeneratio...
May 12, 2025
Datamonitor Healthcare Oncology Dis...
May 9, 2025
2025 Biomedtracker Datamonitor Hea...
May 8, 2025
Wet AMD KOL- France
May 8, 2025
Datamonitor Healthcare Oncology: NH...
May 8, 2025
Wet AMD KOL- US, South
May 7, 2025
Datamonitor Healthcare Infectious D...
May 6, 2025
Datamonitor Healthcare CV&Met: Sick...
May 6, 2025
Dealmaking Quarterly Statistics, Q1...
May 5, 2025
Datamonitor Healthcare I&I: Heredit...
May 1, 2025
Ovarian Cancer - KOL Interview - US...
May 21, 2025
Datamonitor Healthcare Oncology Dis...
May 21, 2025
Datamonitor Healthcare CNS Disease ...
May 21, 2025
Datamonitor Healthcare I&I: Opioid-...
May 21, 2025
Gene, Cell, & RNA Therapy Landscape...
May 16, 2025
Epilepsy KOL Interview - France
May 16, 2025
Datamonitor Healthcare Oncology: Pa...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 14, 2025
Datamonitor Healthcare CNS: Insomni...
May 13, 2025
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 5/21/25 | Merck KGaA (MKKGY) | Enpatoran for Systemic Lupus Erythematosus (SLE) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/21/25 | Pfizer (PFE) | Talzenna for Prostate Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/21/25 | UroGen Pharma (URGN) | VesiGel for Bladder Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/20/25 | Respira Therapeutics | RT234 for Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/20/25 | Roche (RO) | Columvi for Diffuse Large B-Cell Lymphoma (DLBCL) - NHL | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 04/01/2025 | Subscribers Only | Subscribers Only | Company - Divestment/Spinoff |
| 04/24/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 05/13/2025 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 05/13/2025 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 05/20/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |